Polymorphisms of the human IFNG gene noncoding regions

Immunogenetics

Volumn 51, Issue 1, 2000, Pages 50-58

  Bream, Jay H ^a   Carrington, Mary ^b   O'Toole, Stefanie ^a   Dean, Michael ^a   Gerrard, Bernard ^b   Shin, Hyoung Doo ^b   Kosack, Daniel ^a   Modi, William ^b   Young, Howard A ^a   Smith, Michael W ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

3'UTR; AIOS; Interferon gamma; Polymorphism; Promoter

Indexed keywords

DNA; GAMMA INTERFERON;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA BINDING; DNA POLYMORPHISM; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRON; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034016053     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050008     Document Type: Article

References (67)

1. Agarwala SS, Kirkwood JM (1996) Interferons in melanoma. Curr Opin Oncol 8:167-174
2. Allison PD (1995) Survival analysis using the SAS system: a practical guide. SAS Handbook 1-292
3. Awata T, Matsumoto C, Urakami T, Hagura R, Amemiya S, Kanazawa Y (1994) Association of polymorphism in the interferon gamma gene with IDDM. Diabetologia 37:1159-1162
4. Aziz N, Nishanian P, Taylor JM, Mitsuyasu RT, Jacobson JM, Dezube BJ, Lederman MM, Detels R, Fahey JL (1999) Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection. J Infect Dis 179:843-848
5. Bailly S, Israel N, Fay M, Gougerot-Pocidalo MA, Duff GW (1996) An intronic polymorphic repeat sequence modulates interleukin-1 alpha gene regulation. Mol Immunol 33:999-1006
6. Belardelli F (1995) Role of interferons and other cytokines in the regulation of the immune response. APMIS 103:161-179
7. Bream JH, Young HA, Rice, Martin MP, Smith MW, Carrington M, O'Brien SJ (1999) CCR5 promoter alleles and specific DNA binding factors. Science 284:223a
8. Breuer-McHam JN, Marshall GD, Lewis DE, Duvic M (1998) Distinct serum cytokines in AIDS-related skin diseases. Viral Immunol 11:215-220
9. Brodie SJ, Sasseville VG, Reimann KA, Simon MA, Sehgal PK, Ringler DJ (1994) Macrophage function in simian AIDS. Killing defects in vivo are independent of macrophage infection, associated with alterations in Th phenotype, and reversible with IFN-gamma. J Immunol 153:5790-5801
10. Centers for Disease Control (1987) Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep 36:1S-15S
11. Centers for Disease Control (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41:1-19
12. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, Trinchieri G (1994) Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 179:1361-1366
13. Cippitelli M, Sica A, Viggiano V, Ye J, Ghosh P, Birrer MJ, Young HA (1995) Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun. J Biol Chem 270:12548-12556
14. Cippitelli M, Ye J, Viggiano V, Sica A, Ghosh P, Gulino A, Santoni A, Young HA (1996) Retinoic acid-induced transcriptional modulation of the human interferon-gamma promoter. J Biol Chem 271:26783-26793
15. Clerici M, Shearer GM (1994) The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 15:575-581
16. Cox DR (1972) Proportional Hazard Regression. J R Stat Soc B 34
17. De Francesco MA, Caruso A, Dima F, Cantalamessa A, Canaris AD, Folghera S, Fiorentini S, Flamminio G, Licenziati S, Peroni L, Gao J, Garotta G, Turano A (1996) IFN-gamma restores HIV-and non-HIV-specific cell mediated immune response in vitro and its activity is neutralized by antibodies from patients with AIDS. Scand J Immunol 43:94-100
18. Decker CJ, Parker R (1995) Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts. Curr Opin Cell Biol 7:386-392
19. Derynck R, Leung DW, Gray PW, Goeddel DV (1982) Human interferon gamma is encoded by a single class of mRNA. Nucleic Acids Res 10:3605-3615
20. Detels R, Liu Z, Hennessey K, Kan J, Visscher BR, Taylor JM, Hoover DR, Rinaldo CRJ, Phair JP, Saah AJ (1994) Resistance to HIV-1 infection. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 7:1263-1269
21. Fiorelli V, Barillari G, Toschi E, Sgadari C, Monini P, Sturzl M, Ensoli B (1999) IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 162:1165-1170
22. Gebhardt F, Zanker KS, Brandt B (1999) Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem 274:13176-13180
23. Goedert JJ, Kessler CM, Aledort LM, Biggar RJ, Andes WA, White GC, Drummond JE, Vaidya K, Mann DL, Eyster ME (1989) A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia [see comments]. N Engl J Med 321:1141-1148
24. Gray PW, Goeddel DV (1982) Structure of the human immune interferon gene. Nature 298:859-863
25. Gray PW, Goeddel DV (1983) Human immune interferon (IFN-gamma) gene sequence and structure. Basic Life Sci 25:35-61
26. Hardy KJ, Manger B, Newton M, Stobo JD (1987) Molecular events involved in regulating human interferon-gamma gene expression during T cell activation. J Immunol 138:2353-2358
27. Hardy KJ, Peterlin BM, Atchison RE, Stobo JD (1985) Regulation of expression of the human interferon gamma gene. Proc Natl Acad Sci USA 82:8173-8177
28. Heagy W, Groopman J, Schindler J, Finberg R (1990) Use of IFN-gamma in patients with AIDS. J Acquir Immune Defic Syndr 3:584-590
29. Hilgartner MW, Donfield SM, Willoughby A, Contant CFJ, Evatt BL, Gomperts ED, Hoots WK, Jason J, Loveland KA, McKinlay SM (1993) Hemophilia growth and development study. Design, methods, and entry data. Am J Pediatr Hematol Oncol 15:208-218
30. John S, Myerscough A, Marlow A, Hajeer A, Silman A, Ollier W, Worthington J (1998) Linkage of cytokine genes to rheumatoid arthritis. Evidence of genetic heterogeneity. Ann Rheum Dis 57:361-365
31. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CRJ (1987) The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 126:310-318
32. Khatri VP, Fehniger TA, Baiocchi RA, Yu F, Shah MH, Schiller DS, Gould M, Gazzinelli RT, Bernstein ZP, Caligiuri MA (1998) Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies. J Clin Invest 101:1373-1378
33. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, Deutsch L, Phair J, Neumann AU, Ho DD (1998) A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 4:350-353
34. Kroeger KM, Carville KS, Abraham LJ (1997) The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:391-399
35. Landolfo S, Gribaudo G, Angeretti A, Gariglio M (1995) Mechanisms of viral inhibition by interferons. Pharmacol Ther 65:415-442
36. Lincoln SE, Daly MJ, Lander ES (1991) PRIMER: A computer program for automatically selecting PCR primers. MIT Center for Genome Research, Cambridge, MA
37. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X, Takamatsu JK, Saito H, Ishikawa Y, Akaza T, Juji T, Takebe Y, Ohishi T, Fukutake K, Maruyama Y, Yashiki S, Sonoda S, Nakamura T, Nagai Y, Iwamoto A, Shioda T (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 96:4581-4585
38. Maggi E, Mazzetti M, Ravina A, Annunziato F, de Carli M, Piccinni MP, Manetti R, Carbonari M, Pesce AM, del Prete G (1994) Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 265:244-248
39. Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW, Margolick J, Buchbinder S, Goedert JJ, O'Brien TR, Hilgartner MW, Vlahov D, O'Brien SJ, Carrington M (1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282:1907-1911
40. McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PM (1998) CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 352:866-870
41. Mikovits JA, Young HA, Vertino P, Issa JP, Pitha PM, Turcoski-Corrales S, Taub DD, Petrow CL, Baylin SB, Ruscetti FW (1998) Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol Cell Biol 18:5166-5177
42. Monteyne P, Bihl F, Levillayer F, Brahic M, Bureau JF (1999) The Th1/Th2 balance does not account for the difference of susceptibility of mouse strains to Theiler's virus persistent infection. J Immunol 162:7330-7334
43. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M (1994) Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921
44. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J (1992) A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 22:396-402
45. Pociot F, Veijola R, Johannesen J, Hansen PM, Lorenzen T, Karlsen AE, Reijonen H, Knip M, Nerup J (1997) Analysis of an interferon-gamma gene (IFNG) polymorphism in Danish and Finnish insulin-dependent diabetes mellitus (IDDM) patients and control subjects. Danish Study Group of Diabetes in Childhood. J Interferon Cytokine Res 17:87-93
46. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV (1999) In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 26:1-3
47. Pravica VP, Borreiro LF, Hutchinson IV (1997) Genetic regulation of interferon-gamma production. Biochem Soc Trans 25:176 S
48. Rosenwasser LJ, Borish L (1997) Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am J Respir Crit Care Med 156:S152-S155
49. Ruiz-Linares A (1993) Dinucleotide repeat polymorphism in the interferon-gamma (IFNG) gene. Hum Mol Genet 2:1508
50. Shearer GM, Clerici M (1998) Cytokine profiles in HFV type 1 disease and protection. AIDS Res Hum Retroviruses 14:S149-52
51. Sica A, Dorman L, Viggiano V, Cippitelli M, Ghosh P, Rice N, Young HA (1997) Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J Biol Chem 272:30412-30420
52. Sica A, Tan TH, Rice N, Kretzschmar M, Ghosh P, Young HA (1992) The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element. Proc Natl Acad Sci USA 89:1740-1744
53. Siegmund T, Usadel KH, Donner H, Braun J, Walfish PG, Badenhoop K (1998) Interferon-gamma gene microsatellite polymorphisms in patients with Graves' disease. Thyroid 8:1013-1017
54. Song Z, Casolaro V, Chen R, Georas SN, Monos D, Ono SJ (1996) Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J Immunol 156:424-429
55. Sousa AE, Chaves AF, Doroana M, Antunes F, Victorino RM (1999) Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection. J Immunol 162:3718-3726
56. Ullum H, Cozzi LA, Bendtzen K, Victor J, Gotzsche PC, Phillips AN, Skinhoj P, Klarlund PB (1997) Low production of interferon gamma is related to disease progression in HIV infection: evidence from a cohort of 347 HIV-infected individuals. AIDS Res Hum Retroviruses 13:1039-1046
57. Vandenbroeck K, Opdenakker G, Goris A, Murru R, Billiau A, Marrosu MG (1998) Interferon-gamma gene polymorphism-associated risk for multiple sclerosis in Sardinia. Ann Neurol 44:841-842
58. Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, Celentano DD, Solomon L, Polk BF (1991) The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 109:75-100
59. Wang Y, Ardestani SK, Liang B, Beckham C, Watson RR (1994) Anti-IL-4 monoclonal antibody and IFN-gamma administration retards development of immune dysfunction and cytokine dysregulation during murine AIDS. Immunology 83:384-389
60. Westby M, Marriott JB, Guckian M, Cookson S, Hay P, Dalgleish AG (1998) Abnormal intracellular IL-2 and interferon-gamma (IFN-gamma) production as HIV-1-assocated markers of immune dysfunction. Clin Exp Immunol 111:257-263
61. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199
62. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, O'Brien SJ (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant.
63. Wu S, Muhleman D, Comings DE (1998) G5644A polymorphism in the interferon-gamma (IFNG) gene. Psychiatr Genet 8:57
64. Xu X, Sun YL, Hoey T (1996) Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273:794-797
65. Ye J, Cippitelli M, Dorman L, Ortaldo JR, Young HA (1996) The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol Cell Biol 16:4744-4753
66. Ye J, Ortaldo JR, Conlon K, Winkler-Pickett R, Young HA (1995) Cellular and molecular mechanisms of IFN-gamma production induced by IL-2 and IL-12 in a human NK cell line. J Leukoc Biol 58:225-233
67. Young HA (1996) Regulation of interferon-gamma gene expression. J Interferon Cytokine Res 16:563-568